Lidocaine
- Product NDC
- 0591-3012
- 11-digit product format
- 005913012
- Labeler code
- 0591
- Product ID
- 0591-3012_39978bb5-e2dd-4036-bfde-5e7908cef04b
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Lidocaine Hydrochloride
- Dosage form
- JELLY
- Route
- TOPICAL
- Labeler
- Actavis Pharma, Inc.
- Application
- ANDA040837
- Marketing category
- ANDA
- Marketing start
- 2015-06-15
- Marketing end
- 2020-11-30
- Substance
- LIDOCAINE HYDROCHLORIDE
- Active strength
- 20 mg/mL
- Pharmacologic classes
- Amide Local Anesthetic [EPC],Amides [CS],Antiarrhythmic [EPC],Local Anesthesia [PE]
- NDC exclude flag
- No
- Listing certified through
- 0000-00-00
- Current FDA listing
- Historical FDA.report record
NDC auxiliary status#
These records are reproduced from FDA’s unfinished, excluded, and compounder listings. They describe what appeared in the source files; a missing record does not establish a regulatory status. View all current auxiliary records, including entries without an NDC. · View the auxiliary file history.
| Dataset | Scope | Product NDC | Package NDC | Code | Status | Reporting period | Source date |
|---|---|---|---|---|---|---|---|
| excluded product | product | 0591-3012 | D | Discontinued by firm | 2026-10-05 | ||
| excluded package | package | 0591-3012 | 0591-3012-26 | D | Discontinued by firm | 2026-10-05 | |
| excluded package | package | 0591-3012 | 0591-3012-30 | D | Discontinued by firm | 2026-10-05 |
Observed NDC auxiliary status history#
This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.
| Captured / source date | Dataset | Scope | Package NDC | Snapshot | Source SHA-256 |
|---|---|---|---|---|---|
| 2025-12-14 17:58 UTC · source 2025-12-05 | excluded product | product | d630ba8d3edf… | 732f749b63fb… | |
| 2025-12-14 17:58 UTC · source 2025-12-05 | excluded package | package | 0591-3012-30 | d630ba8d3edf… | 732f749b63fb… |
| 2025-12-14 17:58 UTC · source 2025-12-05 | excluded package | package | 0591-3012-26 | d630ba8d3edf… | 732f749b63fb… |
| 2025-08-27 00:01 UTC · source 2025-08-26 | excluded product | product | f5e01cc5f278… | a2eaf40c39c3… | |
| 2025-08-27 00:01 UTC · source 2025-08-26 | excluded package | package | 0591-3012-30 | f5e01cc5f278… | a2eaf40c39c3… |
| 2025-08-27 00:01 UTC · source 2025-08-26 | excluded package | package | 0591-3012-26 | f5e01cc5f278… | a2eaf40c39c3… |
| 2025-04-01 02:39 UTC · source 2025-03-31 | excluded product | product | 2ef7874e63bc… | 57b86245f4fa… | |
| 2025-04-01 02:39 UTC · source 2025-03-31 | excluded package | package | 0591-3012-30 | 2ef7874e63bc… | 57b86245f4fa… |
| 2025-04-01 02:39 UTC · source 2025-03-31 | excluded package | package | 0591-3012-26 | 2ef7874e63bc… | 57b86245f4fa… |
| 2025-03-28 20:22 UTC · source 2025-03-28 | excluded product | product | a1b67e2a42f9… | c4cf2c586c0d… | |
| 2025-03-28 20:22 UTC · source 2025-03-28 | excluded package | package | 0591-3012-30 | a1b67e2a42f9… | c4cf2c586c0d… |
| 2025-03-28 20:22 UTC · source 2025-03-28 | excluded package | package | 0591-3012-26 | a1b67e2a42f9… | c4cf2c586c0d… |
| 2025-03-22 03:12 UTC · source 2025-03-21 | excluded product | product | cfe11265f3b6… | 090c488252e2… | |
| 2025-03-22 03:12 UTC · source 2025-03-21 | excluded package | package | 0591-3012-30 | cfe11265f3b6… | 090c488252e2… |
| 2025-03-22 03:12 UTC · source 2025-03-21 | excluded package | package | 0591-3012-26 | cfe11265f3b6… | 090c488252e2… |
| 2025-03-10 12:48 UTC · source 2025-03-10 | excluded product | product | cdf11ea48f46… | ba0047e9e063… | |
| 2025-03-10 12:48 UTC · source 2025-03-10 | excluded package | package | 0591-3012-30 | cdf11ea48f46… | ba0047e9e063… |
| 2025-03-10 12:48 UTC · source 2025-03-10 | excluded package | package | 0591-3012-26 | cdf11ea48f46… | ba0047e9e063… |
| 2025-02-02 03:52 UTC · source 2025-01-31 | excluded product | product | 302b2466d912… | e7b80fea0513… | |
| 2025-02-02 03:52 UTC · source 2025-01-31 | excluded package | package | 0591-3012-30 | 302b2466d912… | e7b80fea0513… |
| 2025-02-02 03:52 UTC · source 2025-01-31 | excluded package | package | 0591-3012-26 | 302b2466d912… | e7b80fea0513… |
| 2025-01-20 13:05 UTC · source 2025-01-20 | excluded product | product | ed331223b511… | 672a5bd82f5f… | |
| 2025-01-20 13:05 UTC · source 2025-01-20 | excluded package | package | 0591-3012-30 | ed331223b511… | 672a5bd82f5f… |
| 2025-01-20 13:05 UTC · source 2025-01-20 | excluded package | package | 0591-3012-26 | ed331223b511… | 672a5bd82f5f… |
| 2025-01-11 03:41 UTC · source 2025-01-10 | excluded product | product | 0efc9e666f02… | f202fb6c5f17… | |
| 2025-01-11 03:41 UTC · source 2025-01-10 | excluded package | package | 0591-3012-30 | 0efc9e666f02… | f202fb6c5f17… |
| 2025-01-11 03:41 UTC · source 2025-01-10 | excluded package | package | 0591-3012-26 | 0efc9e666f02… | f202fb6c5f17… |
| 2024-11-09 02:27 UTC · source 2024-11-08 | excluded product | product | ad56d346431e… | cc804d4bbf1e… | |
| 2024-11-09 02:27 UTC · source 2024-11-08 | excluded package | package | 0591-3012-30 | ad56d346431e… | cc804d4bbf1e… |
| 2024-11-09 02:27 UTC · source 2024-11-08 | excluded package | package | 0591-3012-26 | ad56d346431e… | cc804d4bbf1e… |
| 2024-10-04 04:10 UTC · source 2024-10-03 | excluded product | product | 367a005e9d99… | 383a685ebd0f… | |
| 2024-10-04 04:10 UTC · source 2024-10-03 | excluded package | package | 0591-3012-30 | 367a005e9d99… | 383a685ebd0f… |
| 2024-10-04 04:10 UTC · source 2024-10-03 | excluded package | package | 0591-3012-26 | 367a005e9d99… | 383a685ebd0f… |
| 2024-07-10 04:00 UTC · source 2024-07-09 | excluded product | product | 557ba5c1ecfa… | 9c80585c8c6e… | |
| 2024-07-10 04:00 UTC · source 2024-07-09 | excluded package | package | 0591-3012-30 | 557ba5c1ecfa… | 9c80585c8c6e… |
| 2024-07-10 04:00 UTC · source 2024-07-09 | excluded package | package | 0591-3012-26 | 557ba5c1ecfa… | 9c80585c8c6e… |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A040837-001 | LIDOCAINE HYDROCHLORIDE | LIDOCAINE HYDROCHLORIDE | 2% | JELLY / TOPICAL | 2011-03-23 |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-09-14 22:38:34 | 2026-08 | A040837-001 | LIDOCAINE HYDROCHLORIDE | 2% | JELLY / TOPICAL | 2011-03-23 | 84e616aacf4f… | ||
| 2026-08-18 06:07:40 | 2026-07 | A040837-001 | LIDOCAINE HYDROCHLORIDE | 2% | JELLY / TOPICAL | 2011-03-23 | caaa826d4ba7… | ||
| 2026-02-19 14:30 UTC | 2026-02 | A040837-001 | LIDOCAINE HYDROCHLORIDE | 2% | JELLY / TOPICAL | 2011-03-23 | 011fe1cb6892… | ||
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A040837-001 | LIDOCAINE HYDROCHLORIDE | 2% | JELLY / TOPICAL | 2011-03-23 | 31067a03dcf5… | ||
| 2025-08-23 18:47 UTC | 2025-08 | A040837-001 | LIDOCAINE HYDROCHLORIDE | 2% | JELLY / TOPICAL | 2011-03-23 | 6a471c1ec25d… | ||
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A040837-001 | LIDOCAINE HYDROCHLORIDE | 2% | JELLY / TOPICAL | 2011-03-23 | fd3edfee7708… | ||
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A040837-001 | LIDOCAINE HYDROCHLORIDE | 2% | JELLY / TOPICAL | 2011-03-23 | b8a1b40f171c… | ||
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A040837-001 | LIDOCAINE HYDROCHLORIDE | 2% | JELLY / TOPICAL | 2011-03-23 | 03ed91905a0d… | ||
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A040837-001 | LIDOCAINE HYDROCHLORIDE | 2% | JELLY / TOPICAL | 2011-03-23 | 2680178bc6a6… | ||
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A040837-001 | LIDOCAINE HYDROCHLORIDE | 2% | JELLY / TOPICAL | 2011-03-23 | 5bbf6a4d5a75… | ||
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A040837-001 | LIDOCAINE HYDROCHLORIDE | 2% | JELLY / TOPICAL | 2011-03-23 | d8e5a09893c0… | ||
| 2024-10-29 15:01 UTC | 2024-10 | A040837-001 | LIDOCAINE HYDROCHLORIDE | 2% | JELLY / TOPICAL | 2011-03-23 | d06236e962d9… | ||
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A040837-001 | LIDOCAINE HYDROCHLORIDE | 2% | JELLY / TOPICAL | 2011-03-23 | 79d66fd596c7… | ||
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | A040837-001 | LIDOCAINE HYDROCHLORIDE | 2% | JELLY / TOPICAL | 2011-03-23 | 301d65b070ca… | ||
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | A040837-001 | LIDOCAINE HYDROCHLORIDE | 2% | JELLY / TOPICAL | 2011-03-23 | 1e350fbaab3a… | ||
| 2024-05-31 18:47 UTC | 2024-05 | A040837-001 | LIDOCAINE HYDROCHLORIDE | 2% | JELLY / TOPICAL | 2011-03-23 | 8072bd15b7f6… | ||
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | A040837-001 | LIDOCAINE HYDROCHLORIDE | 2% | JELLY / TOPICAL | 2011-03-23 | 5c6f7cd8ea54… | ||
| 2022-04-08 23:34 UTC | 2022-04 | A040837-001 | LIDOCAINE HYDROCHLORIDE | 2% | JELLY / TOPICAL | 2011-03-23 | 5d02ea3f76ae… | ||
| 2022-04-04 05:41 UTC | 2022-04 | A040837-001 | LIDOCAINE HYDROCHLORIDE | 2% | JELLY / TOPICAL | 2011-03-23 | 4b0b4de00fa7… | ||
| 2019-12-13 00:20 UTC | 2019-12 | A040837-001 | LIDOCAINE HYDROCHLORIDE | 2% | JELLY / TOPICAL | 2011-03-23 | 74a2ff9319b5… | ||
| 2022-03-09 01:35 UTC | 2022-03 | A040837-001 | LIDOCAINE HYDROCHLORIDE | 2% | JELLY / TOPICAL | 2011-03-23 | bb7c543d1eb4… | ||
| 2021-12-28 21:50 UTC | 2021-12 | A040837-001 | LIDOCAINE HYDROCHLORIDE | 2% | JELLY / TOPICAL | 2011-03-23 | 782e0a99824c… | ||
| 2021-05-05 16:15 UTC · 3 captures of this ZIP | 2021-05 | A040837-001 | LIDOCAINE HYDROCHLORIDE | 2% | JELLY / TOPICAL | 2011-03-23 | 87673890dc5c… | ||
| 2021-03-12 10:30 UTC | 2021-03 | A040837-001 | LIDOCAINE HYDROCHLORIDE | 2% | JELLY / TOPICAL | 2011-03-23 | 5aa47cf7b7d7… | ||
| 2020-12-22 03:56 UTC | 2020-12 | A040837-001 | LIDOCAINE HYDROCHLORIDE | 2% | JELLY / TOPICAL | 2011-03-23 | 8869cabd3fbd… | ||
| 2020-11-12 02:37 UTC | 2020-11 | A040837-001 | LIDOCAINE HYDROCHLORIDE | 2% | JELLY / TOPICAL | 2011-03-23 | c0c555d07b60… | ||
| 2019-12-14 00:12 UTC | 2019-12 | A040837-001 | LIDOCAINE HYDROCHLORIDE | 2% | JELLY / TOPICAL | 2011-03-23 | 3f01610625f2… | ||
| 2019-09-15 20:21 UTC | 2019-09 | A040837-001 | LIDOCAINE HYDROCHLORIDE | 2% | JELLY / TOPICAL | 2011-03-23 | b00525d2431f… | ||
| 2019-07-19 19:46 UTC | 2019-07 | A040837-001 | LIDOCAINE HYDROCHLORIDE | 2% | JELLY / TOPICAL | 2011-03-23 | ea99ee380514… | ||
| 2024-03-16 18:09 UTC · 4 captures of this ZIP | 2024-03 | A040837-001 | LIDOCAINE HYDROCHLORIDE | 2% | JELLY / TOPICAL | 2011-03-23 | 6a51e52b5d6a… | ||
| 2024-02-18 07:12 UTC | 2024-02 | A040837-001 | LIDOCAINE HYDROCHLORIDE | 2% | JELLY / TOPICAL | 2011-03-23 | 1c564ffb4f44… | ||
| 2023-12-20 04:57 UTC | 2023-12 | A040837-001 | LIDOCAINE HYDROCHLORIDE | 2% | JELLY / TOPICAL | 2011-03-23 | ea1830bbd6c7… | ||
| 2023-11-28 05:40 UTC · 2 captures of this ZIP | 2023-11 | A040837-001 | LIDOCAINE HYDROCHLORIDE | 2% | JELLY / TOPICAL | 2011-03-23 | a72a2bbeb626… | ||
| 2023-10-25 00:34 UTC · 2 captures of this ZIP | 2023-10 | A040837-001 | LIDOCAINE HYDROCHLORIDE | 2% | JELLY / TOPICAL | 2011-03-23 | 9b2671bbb829… | ||
| 2023-07-15 15:27 UTC · 2 captures of this ZIP | 2023-07 | A040837-001 | LIDOCAINE HYDROCHLORIDE | 2% | JELLY / TOPICAL | 2011-03-23 | a67488948f0b… | ||
| 2023-06-13 01:57 UTC · 3 captures of this ZIP | 2023-06 | A040837-001 | LIDOCAINE HYDROCHLORIDE | 2% | JELLY / TOPICAL | 2011-03-23 | 3f0d92c62455… | ||
| 2023-05-13 08:27 UTC | 2023-05 | A040837-001 | LIDOCAINE HYDROCHLORIDE | 2% | JELLY / TOPICAL | 2011-03-23 | 053a50430f4f… | ||
| 2023-01-26 05:58 UTC | 2023-01 | A040837-001 | LIDOCAINE HYDROCHLORIDE | 2% | JELLY / TOPICAL | 2011-03-23 | 3bdfa0b2c4d7… | ||
| 2022-11-12 20:34 UTC · 5 captures of this ZIP | 2022-11 | A040837-001 | LIDOCAINE HYDROCHLORIDE | 2% | JELLY / TOPICAL | 2011-03-23 | 3a93d1ddd44b… | ||
| 2022-10-28 04:53 UTC | 2022-10 | A040837-001 | LIDOCAINE HYDROCHLORIDE | 2% | JELLY / TOPICAL | 2011-03-23 | f41ea6bd6efb… |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
DailyMed Product Concepts#
| Product concept | Relation | Version | Effective |
|---|---|---|---|
| 070fbed5-7088-434a-a7ce-f2a64d8d40ac | Product name | 2 | 20260107 |
| bee66ce1-adb7-9d3b-67d9-582e4c54e80f | Product name | 5 | 20250819 |
| 860a93dc-4863-49cc-b284-6bbe8191bc48 | Product name | 4 | 20250214 |
| eaba870a-6a9d-442e-8643-87b3f558a451 | Product name | 1 | 20250117 |
| 9b4cf230-fd05-41d5-98c6-5db9ecb27b86 | Product name | 1 | 20230117 |
| 7d755fa1-1087-4dcd-98f0-6d4bba479a57 | Product name | 3 | 20210602 |
| aed701d5-9c75-dfaf-7154-cde46179faea | Product name | 9 | 20200313 |
| fa8b5901-e681-426f-82fe-54f6d81ec698 | Product name | 4 | 20180619 |
| 332d03e4-aa24-4b11-841a-02bf41081920 | Product name | 1 | 20171221 |
| c08ab52f-2fc8-4409-9d9f-ed8edc0bd070 | Product name | 1 | 20171221 |
| 68ed98f8-24c2-44a0-944a-6d36e82ce25a | Product name | 1 | 20141222 |
| 1cd42bc2-a430-c72b-636d-991b235fbf80 | Product name | 1 | 20140508 |
| 49fa150c-f0de-cce7-3d9c-993ed81c5698 | Product name | 1 | 20140508 |
| 4d7ae718-ed00-bae8-2abe-9eaec1eef7ff | Product name | 1 | 20140508 |
| 9137811f-f279-8640-5aeb-99fa2145d64d | Product name | 1 | 20140508 |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 0591-3012-26 | ML - Milliliter | 0591-3012 | dcc2fe6f-2bfc-45f9-ac19-fd89bf2fb008 | 1 | 2016-02-04 |
| 0591-3012-30 | ML - Milliliter | 0591-3012 | 1280e116-7ee2-43eb-917d-b74c2abf2d93 | 1 | 2015-09-10 |
DailyMed Socrata Ingredients#
| Ingredient | Type | UNII | DailyMed label | SPL version | Uploaded |
|---|---|---|---|---|---|
| LIDOCAINE HYDROCHLORIDE | ACTIVE INGREDIENT | V13007Z41A | LIDOCAINE (LIDOCAINE HYDROCHLORIDE) JELLY [ACTAVIS PHARMA, INC.] | 1 | |
| LIDOCAINE | ACTIVE MOIETY | 98PI200987 | LIDOCAINE (LIDOCAINE HYDROCHLORIDE) JELLY [ACTAVIS PHARMA, INC.] | 1 | |
| HYDROCHLORIC ACID | INACTIVE INGREDIENT | QTT17582CB | LIDOCAINE (LIDOCAINE HYDROCHLORIDE) JELLY [ACTAVIS PHARMA, INC.] | 1 | |
| HYPROMELLOSES | INACTIVE INGREDIENT | 3NXW29V3WO | LIDOCAINE (LIDOCAINE HYDROCHLORIDE) JELLY [ACTAVIS PHARMA, INC.] | 1 | |
| METHYLPARABEN | INACTIVE INGREDIENT | A2I8C7HI9T | LIDOCAINE (LIDOCAINE HYDROCHLORIDE) JELLY [ACTAVIS PHARMA, INC.] | 1 | |
| PROPYLPARABEN | INACTIVE INGREDIENT | Z8IX2SC1OH | LIDOCAINE (LIDOCAINE HYDROCHLORIDE) JELLY [ACTAVIS PHARMA, INC.] | 1 | |
| SODIUM HYDROXIDE | INACTIVE INGREDIENT | 55X04QC32I | LIDOCAINE (LIDOCAINE HYDROCHLORIDE) JELLY [ACTAVIS PHARMA, INC.] | 1 |
DailyMed RxNorm Mappings#
| RxCUI | RxNorm string | TTY | DailyMed | SPL version |
|---|---|---|---|---|
| 1011852 | lidocaine HCl 2 % Topical Gel | PSN | 008e8da2-1390-457b-89dd-41de33611942 | 2 |
| 1011852 | lidocaine HCl 2 % Topical Gel | PSN | 46247b76-1ceb-4591-9aad-f5fbb5d5b0b8 | 2 |
| 1011852 | lidocaine hydrochloride 0.02 MG/MG Topical Gel | SCD | 008e8da2-1390-457b-89dd-41de33611942 | 2 |
| 1011852 | lidocaine hydrochloride 0.02 MG/MG Topical Gel | SCD | 46247b76-1ceb-4591-9aad-f5fbb5d5b0b8 | 2 |
| 1011852 | lidocaine hydrochloride 2 % Topical Jelly | SY | 008e8da2-1390-457b-89dd-41de33611942 | 2 |
| 1011852 | lidocaine hydrochloride 2 % Topical Jelly | SY | 46247b76-1ceb-4591-9aad-f5fbb5d5b0b8 | 2 |